https://doi.org/10.1038/s41467-021-21795-z
M
Min Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
179
Papers
3.8K
Citations
33
h-index
72
i10-index
Min Luo is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Immune cells in cancer & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 33, co-authored 153 publications.
ORCID: 0000-0001-5732-4848Papers by this author
worksComprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
2021 · Nature Communications · 205 citations
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
2021 · Cell Research · 171 citations
https://doi.org/10.1038/s41422-021-00528-3
CD300ld on neutrophils is required for tumour-driven immune suppression
2023 · Nature · 154 citations
https://doi.org/10.1038/s41586-023-06511-9
Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
2021 · Molecular Cancer · 135 citations
https://doi.org/10.1186/s12943-021-01307-9
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio
2015 · Head & Neck · 121 citations
https://doi.org/10.1002/hed.24224
ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma
2023 · Biochemical Pharmacology · 65 citations
https://doi.org/10.1016/j.bcp.2023.115554
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat